Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

AstraZeneca AZ

AZ to address Imfinzi setback, but sees potential with Tagrisso

Pharma giant to deliver oncology pipeline update at AACR

- PMLiVE

Roche gets EU nod for much-expanded Hemlibra label

Drug is now suitable for all age groups with multiple dosing options

- PMLiVE

More Brexit chaos as government suffers more defeats

UK parliament rejects a no-deal Brexit

My adventure into the world of Medcomms and Lucid’s Futures Academy

After finishing my PhD, I was disillusioned with the lab. I felt that I wanted more out of my career than working on one protein, in one pathway, for the...

Lucid Group Communications Limited

- PMLiVE

Oxford Biomedica taps Microsoft to progress gene therapy delivery tech

Will develop in silico models and novel algorithms

- PMLiVE

Celgene’s Abraxane fails pancreatic cancer trial

Abraxane failed to show improvement in disease-free survival

- PMLiVE

NCI head Sharpless named as interim FDA chief

The search for a permanent replacement is still ongoing

- PMLiVE

NICE partially clears Darzalex combo in blood cancer

Approved in second-line use under  CDF

- PMLiVE

Brexit deal defeated again, crucial no-deal vote awaits

UK pharma urges no-deal to be ruled out

01000010 01101001 01101110 01100001 01110010 01111001

Success and failure is a binary outcome

- PMLiVE

Bedrock keep it in the family

Recent filming project really is a family affair

Bedrock Healthcare Communications

Graduation day is celebrated by Lucid’s third Futures Academy cohort

Lucid’s Futures Academy is proud to release its most recent cohort of graduates into the business for the first of their two rotations.The Futures Academy begins with an eight-week intensive...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links